Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.
Saved in:
| Title: | Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. |
|---|---|
| Authors: | Krausewitz P; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de., Essler M; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany., Gaertner FC; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany., Attenberger U; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany., Luetkens JA; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany., Kristiansen G; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Bernhardt M; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Ohlmann CH; Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and., Anspach M; Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and., Schmid M; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany., Nemeth R; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany., Schmitz J; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany., Hauser S; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany., Ellinger J; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany., Ritter M; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jan 02; Vol. 67 (1), pp. 60-66. Date of Electronic Publication: 2026 Jan 02. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41198235 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Krausewitz+P%22">Krausewitz P</searchLink>; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de.<br /><searchLink fieldCode="AU" term="%22Essler+M%22">Essler M</searchLink>; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Gaertner+FC%22">Gaertner FC</searchLink>; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Attenberger+U%22">Attenberger U</searchLink>; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Luetkens+JA%22">Luetkens JA</searchLink>; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Kristiansen+G%22">Kristiansen G</searchLink>; Institute of Pathology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Bernhardt+M%22">Bernhardt M</searchLink>; Institute of Pathology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Ohlmann+CH%22">Ohlmann CH</searchLink>; Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and.<br /><searchLink fieldCode="AU" term="%22Anspach+M%22">Anspach M</searchLink>; Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and.<br /><searchLink fieldCode="AU" term="%22Schmid+M%22">Schmid M</searchLink>; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Nemeth+R%22">Nemeth R</searchLink>; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitz+J%22">Schmitz J</searchLink>; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Hauser+S%22">Hauser S</searchLink>; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Ellinger+J%22">Ellinger J</searchLink>; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Ritter+M%22">Ritter M</searchLink>; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2026 Jan 02; Vol. 67 (1), pp. 60-66. <i>Date of Electronic Publication: </i>2026 Jan 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41198235 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.125.271344 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 60 Titles: – TitleFull: Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Krausewitz P – PersonEntity: Name: NameFull: Essler M – PersonEntity: Name: NameFull: Gaertner FC – PersonEntity: Name: NameFull: Attenberger U – PersonEntity: Name: NameFull: Luetkens JA – PersonEntity: Name: NameFull: Kristiansen G – PersonEntity: Name: NameFull: Bernhardt M – PersonEntity: Name: NameFull: Ohlmann CH – PersonEntity: Name: NameFull: Anspach M – PersonEntity: Name: NameFull: Schmid M – PersonEntity: Name: NameFull: Nemeth R – PersonEntity: Name: NameFull: Schmitz J – PersonEntity: Name: NameFull: Hauser S – PersonEntity: Name: NameFull: Ellinger J – PersonEntity: Name: NameFull: Ritter M IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 01 Text: 2026 Jan 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 67 – Type: issue Value: 1 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |
